Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1962 2
1963 2
1964 2
1965 1
1966 2
1967 1
1970 1
1977 2
1978 1
1981 1
1982 1
1984 1
1985 1
1986 3
1987 2
1988 1
1989 3
1990 1
1992 2
1995 1
2004 1
2006 1
2008 1
2016 1
2022 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Abraham JE, Pinilla K, Dayimu A, Grybowicz L, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra A, Qian W, Vallier AL, Hardy RM, Chan S, Hickish T, Tripathi D, Venkitaraman R, Persic M, Aslam S, Glassman D, Raj S, Borley A, Braybrooke JP, Sutherland S, Staples E, Scott LC, Davies M, Palmer CA, Moody M, Churn MJ, Newby JC, Mukesh MB, Chakrabarti A, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Tischkowitz M, Provenzano E, Earl HM. Abraham JE, et al. Among authors: roberts an. Nature. 2024 May;629(8014):1142-1148. doi: 10.1038/s41586-024-07384-2. Epub 2024 Apr 8. Nature. 2024. PMID: 38588696 Free PMC article. Clinical Trial.
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.
Abraham JE, O'Connor LO, Grybowicz L, Alba KP, Dayimu A, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra MA, Qian W, Brown J, Hardy R, Vallier AL, Chan S, Cidon MEU, Sherwin E, Chakrabarti A, Sadler C, Barnes J, Persic M, Smith S, Raj S, Borley A, Braybrooke JP, Staples E, Scott LC, Palmer CA, Moody M, Churn MJ, Pilger D, Zagnoli-Vieira G, Wijnhoven PWG, Mukesh MB, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Galbraith S, Tischkowitz M, Provenzano E, O'Connor MJ, Earl HM; PARTNER Trial Group. Abraham JE, et al. Among authors: roberts an. Nat Commun. 2025 May 13;16(1):4269. doi: 10.1038/s41467-025-59151-0. Nat Commun. 2025. PMID: 40360463 Free PMC article. Clinical Trial.
Isoform-specific functions of PPARγ in gene regulation and metabolism.
Hu W, Jiang C, Kim M, Xiao Y, Richter HJ, Guan D, Zhu K, Krusen BM, Roberts AN, Miller J, Steger DJ, Lazar MA. Hu W, et al. Among authors: roberts an. Genes Dev. 2022 Mar 1;36(5-6):300-312. doi: 10.1101/gad.349232.121. Epub 2022 Mar 10. Genes Dev. 2022. PMID: 35273075 Free PMC article.
Prolactin and breast cancer risk.
Ingram DM, Nottage EM, Roberts AN. Ingram DM, et al. Among authors: roberts an. Med J Aust. 1990 Oct 15;153(8):469-73. Med J Aust. 1990. PMID: 2215338
Three deaths from hemlock poisoning.
Drummer OH, Roberts AN, Bedford PJ, Crump KL, Phelan MH. Drummer OH, et al. Among authors: roberts an. Med J Aust. 1995 Jun 5;162(11):592-3. doi: 10.5694/j.1326-5377.1995.tb138553.x. Med J Aust. 1995. PMID: 7791646 No abstract available.
44 results